Moon? I’m starting to wonder if there’s enough water for cities on earth.
Batttlezone was the tank game.
What are their data privacy and security policies? That is an important consideration.
…and a trusted doctor isn’t necessarily a replacement for the CDC.
Nice work! Love it.
Wtf world do we live in that this sentence exists.
To add a somewhat cynical view, a significant part of the original motivation for the ranibizumab (Lucentis) development was due to pricing arbitrage across diseases. bevicizumab was priced based on uses in cancer…
I agree with you that AAV is clearly a useful tool but at times the low levels of self discipline and scientific rigor that the field has applied to dosing is disappointing at best and scary at times. This includes use…
I suspect there is a deep sequencing service that is non CLIA and cheap. True. they may not be trustworthy with the data. That said, there are steps here where the data is put into Claude. Do we trust that ?
Maybe also an interesting case study in the inconsistent application of copyright law.
I think their point is not the ESG component, but firms with traditionally irrational valuations (à la GameStop) for which index inclusion exceptions have been made to facilitate short term liquidity for IPO…
I can’t wait until Thanksgiving.
[dead]
Just in that it’s not gonna work.
…Better plan all day Better plan all week, better plan all month, better plan all year…. (Sorry, esoteric song lyric that applies.)
Interesting analogy.
This is interesting. As a naive user I’ve gotten the gut feeling of commoditization among the models. I assumed the data center capacity push is intended to be the differentiator but that still seems utility-like over…
(not intending ot be snarky, but this isn't my area of knowledge in the least.) Didn't the AI organizations 'get it both ways' when they trained on vast collection of works under copyright and then purely "own' the…
You've succinctly identified and communicated a real problem. In your opinion, what is the best approach, if any, to attempt to address it?
Put this way, this seems reasonable. Beyond cell therapy, I don't thin the cost of drug is the motivation for not making it more freely available. 'Misuse' leading to potential liability or unjustified bad outcomes,…
So charging patients/insurance companies at cost to fund the clinical studies?
Not even cost plus? Not sure how that works, from the viewpoint of economic incentives.
Knowing whether drugs work isn’t trivial. Patients are typically very heterogeneous in their responses to drugs. For example, pembrolizumab (the most successful cancer drug ever) typically only works in, say 30% of…
Cane you provide a list of the “stupid” drug approvals?
lol. The battery life seems so short, I was starting to wonder whether this was the case...
Moon? I’m starting to wonder if there’s enough water for cities on earth.
Batttlezone was the tank game.
What are their data privacy and security policies? That is an important consideration.
…and a trusted doctor isn’t necessarily a replacement for the CDC.
Nice work! Love it.
Wtf world do we live in that this sentence exists.
To add a somewhat cynical view, a significant part of the original motivation for the ranibizumab (Lucentis) development was due to pricing arbitrage across diseases. bevicizumab was priced based on uses in cancer…
I agree with you that AAV is clearly a useful tool but at times the low levels of self discipline and scientific rigor that the field has applied to dosing is disappointing at best and scary at times. This includes use…
I suspect there is a deep sequencing service that is non CLIA and cheap. True. they may not be trustworthy with the data. That said, there are steps here where the data is put into Claude. Do we trust that ?
Maybe also an interesting case study in the inconsistent application of copyright law.
I think their point is not the ESG component, but firms with traditionally irrational valuations (à la GameStop) for which index inclusion exceptions have been made to facilitate short term liquidity for IPO…
I can’t wait until Thanksgiving.
[dead]
Just in that it’s not gonna work.
…Better plan all day Better plan all week, better plan all month, better plan all year…. (Sorry, esoteric song lyric that applies.)
Interesting analogy.
This is interesting. As a naive user I’ve gotten the gut feeling of commoditization among the models. I assumed the data center capacity push is intended to be the differentiator but that still seems utility-like over…
(not intending ot be snarky, but this isn't my area of knowledge in the least.) Didn't the AI organizations 'get it both ways' when they trained on vast collection of works under copyright and then purely "own' the…
You've succinctly identified and communicated a real problem. In your opinion, what is the best approach, if any, to attempt to address it?
Put this way, this seems reasonable. Beyond cell therapy, I don't thin the cost of drug is the motivation for not making it more freely available. 'Misuse' leading to potential liability or unjustified bad outcomes,…
So charging patients/insurance companies at cost to fund the clinical studies?
Not even cost plus? Not sure how that works, from the viewpoint of economic incentives.
Knowing whether drugs work isn’t trivial. Patients are typically very heterogeneous in their responses to drugs. For example, pembrolizumab (the most successful cancer drug ever) typically only works in, say 30% of…
Cane you provide a list of the “stupid” drug approvals?
lol. The battery life seems so short, I was starting to wonder whether this was the case...